Last updated at 17 Jul 2025 12:38 PM
Director
DIN: 08781707
Ankit Jain is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at SATIYA NUTRACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08781707.Ankit Jain has previously been associated with 24 companies in roles such as Additional Director, Designated Partner, CFO and Director.Ankit Jain is currently involved in 2 different roles. Their most recent position is with ANKAM VENTURES LLP as a Designated Partner. The first company Ankit Jain was appointed to as a director was SATIYA NUTRACEUTICALS PRIVATE LIMITED. Ankit Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ankit Jain is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at SATIYA NUTRACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08781707.Ankit Jain has previously been associated with 24 companies in roles such as Additional Director, Designated Partner, CFO and Director.Ankit Jain is currently involved in 2 different roles. Their most recent position is with ANKAM VENTURES LLP as a Designated Partner. The first company Ankit Jain was appointed to as a director was SATIYA NUTRACEUTICALS PRIVATE LIMITED. Ankit Jain is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (24)
1y 1m 7 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
SATIYA NUTRACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2024 |